Case Study Interprets Continuous Process Verification Guidance - - BioPharm International

ADVERTISEMENT

Case Study Interprets Continuous Process Verification Guidance


BioPhorum Operations Group (BPOG) has published a resource to help the biopharmaceutical industry deliver a high quality, consistent approach to continued process verification (CPV). The resource, a case study developed in response to Stage 3 process verification guidance from the FDA, is designed to help companies develop their own CPV approach by providing best practices and guidance on how to implement and demonstrate effective process validation.

The 100-page case study, “Continued Process Verification: An Industry Position Paper with Example Plan,” was written by subject matter experts from major biotech manufacturers. The document describes the thought processes behind the creation of a CPV plan.  Containing a model plan based on a generic monoclonal antibody (mAb) production process, the case study makes it clear how critical process parameters are identified, analyzed, and reported for every step in the process.

Source: BioPhorum Operations Group

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines

Click here